METTL14 and neoplasm: Furthermore, upregulation of METTL14 mediates cisplatin resistance through activating the AMPKα/ERK1/2/mTOR pathway to reduce autophagy and apoptosis, resulting in accelerated tumor proliferation and metastasis [233].